A SUBSTRATE-LIKE FORM OF PLASMINOGEN-ACTIVATOR-INHIBITOR TYPE-1 - CONVERSIONS BETWEEN DIFFERENT FORMS BY SODIUM DODECYL-SULFATE

被引:98
作者
URANO, T
STRANDBERG, L
JOHANSSON, LBA
NY, T
机构
[1] UMEA UNIV, DEPT APPL CELL & MOLEC BIOL, S-90187 UMEA, SWEDEN
[2] UMEA UNIV, DEPT PHYS CHEM, S-90187 UMEA, SWEDEN
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1992年 / 209卷 / 03期
关键词
D O I
10.1111/j.1432-1033.1992.tb17372.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recombinant plasminogen-activator-inhibitor type 1 (PAI-1) purified in an active form from Escherichia coli and eucaryotic cells was found to contain a mixture of three functionally distinct forms: an active form that forms complexes with plasminogen activators (PAs), an inactive (latent) form that remains intact after incubation with PAs, and a substrate-like form which is easily cleaved by PAs. Since active PAI-1 purified from bacteria (rpPAI-1) contains only trace amounts of the inactive latent and the substrate-like forms, this material was used to study the effect of sodium dodecyl sulphate (SDS) on the structure and function of active PAI-1. After treatment with 0.01% SDS, active rpPAI-1 was converted to an inactive form that did not form complexes with PAs, but exhibited characteristics similar to those of latent PAI-1. After treatment with 0.1 % SDS, PAI-1 lost its inhibitory activity and was cleaved as a substrate in the reactive center. Circular dichroism spectral analysis reveals that SDS changed the conformation of PAI-1 dramatically, mainly by increasing its alpha-helical content.
引用
收藏
页码:985 / 992
页数:8
相关论文
共 59 条
  • [1] PURIFICATION AND CHARACTERIZATION OF NATURAL AND RECOMBINANT HUMAN-PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
    ALESSI, MC
    DECLERCK, PJ
    DEMOL, M
    NELLES, L
    COLLEN, D
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 175 (03): : 531 - 540
  • [2] PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 - REACTIVE CENTER AND AMINO-TERMINAL HETEROGENEITY DETERMINED BY PROTEIN AND CDNA SEQUENCING
    ANDREASEN, PA
    RICCIO, A
    WELINDER, KG
    DOUGLAS, R
    SARTORIO, R
    NIELSEN, LS
    OPPENHEIMER, C
    BLASI, F
    DANO, K
    [J]. FEBS LETTERS, 1986, 209 (02) : 213 - 218
  • [3] BACHMANN F, 1987, THROMB DIATH HAEMO, P227
  • [4] PLASMINOGEN-ACTIVATOR INHIBITOR FROM HUMAN-ENDOTHELIAL CELLS - PURIFICATION AND PARTIAL CHARACTERIZATION
    BOOTH, NA
    MACGREGOR, IR
    HUNTER, NR
    BENNETT, B
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1987, 165 (03): : 595 - 600
  • [5] DETERMINATION OF PROTEIN SECONDARY STRUCTURE IN SOLUTION BY VACUUM ULTRAVIOLET CIRCULAR-DICHROISM
    BRAHMS, S
    BRAHMS, J
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1980, 138 (02) : 149 - 178
  • [6] BRUCH M, 1988, J BIOL CHEM, V263, P16626
  • [7] ALPHA-1-ANTITRYPSIN AND THE SERPINS - VARIATION AND COUNTERVARIATION
    CARRELL, R
    TRAVIS, J
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1985, 10 (01) : 20 - 24
  • [8] Carrell R.W, 1986, PROTEINASE INHIBITOR, P403
  • [9] MOBILE REACTIVE CENTER OF SERPINS AND THE CONTROL OF THROMBOSIS
    CARRELL, RW
    EVANS, DL
    STEIN, PE
    [J]. NATURE, 1991, 353 (6344) : 576 - 578
  • [10] THE SERPINS - EVOLUTION AND ADAPTATION IN A FAMILY OF PROTEASE INHIBITORS
    CARRELL, RW
    PEMBERTON, PA
    BOSWELL, DR
    [J]. COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1987, 52 : 527 - 535